In the context of MetS, angiotensin II (Ang II) is considered a key regulator of not only vasomotor functions, but also inflammation of adipose tissue [2,5,6], and these activities are mediated mainly by activation of the Ang II type 1 (AT1) receptor. The gene discussed is AGT; the disease is metabolic syndrome.